Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	5,919	2,759	2,718	2,990	2,531	3,181	Upgrade
Market Cap Growth	61.15%	1.50%	-9.09%	18.11%	-20.42%	119.95%	Upgrade
Enterprise Value	5,038	2,289	2,529	2,815	2,044	3,900	Upgrade
Last Close Price	13.15	6.19	5.06	6.16	8.63	-	Upgrade
PE Ratio	83.55	301.58	-	-	-	-	Upgrade
PS Ratio	0.70	0.37	0.38	0.49	0.41	0.56	Upgrade
PB Ratio	4.95	2.67	2.51	3.19	2.10	3.36	Upgrade
P/TBV Ratio	11.17	6.24	5.93	8.80	4.47	12.53	Upgrade
P/FCF Ratio	9.18	10.04	86.84	-	-	-	Upgrade
P/OCF Ratio	7.14	6.20	15.26	-	17.45	-	Upgrade
EV/Sales Ratio	0.61	0.30	0.35	0.46	0.33	0.69	Upgrade
EV/EBITDA Ratio	11.10	7.79	-	-	-	-	Upgrade
EV/EBIT Ratio	17.57	12.38	-	-	-	-	Upgrade
EV/FCF Ratio	7.82	8.32	80.79	-	-	-	Upgrade
Debt / Equity Ratio	0.46	0.50	0.49	0.66	0.46	1.19	Upgrade
Debt / EBITDA Ratio	1.19	1.54	-	-	-	-	Upgrade
Debt / FCF Ratio	0.86	1.89	16.78	-	-	-	Upgrade
Asset Turnover	1.29	1.32	1.27	1.29	1.28	1.11	Upgrade
Inventory Turnover	5.68	5.34	4.68	5.73	4.83	3.19	Upgrade
Quick Ratio	0.75	0.73	0.61	0.53	0.74	0.55	Upgrade
Current Ratio	1.01	1.00	0.97	0.86	1.07	0.97	Upgrade
Return on Equity (ROE)	6.05%	0.89%	-32.63%	-51.30%	-25.07%	-17.08%	Upgrade
Return on Assets (ROA)	2.82%	2.02%	-2.21%	-7.84%	-1.84%	-6.26%	Upgrade
Return on Capital (ROIC)	10.68%	7.57%	-7.74%	-23.09%	-4.84%	-16.78%	Upgrade
Return on Capital Employed (ROCE)	11.90%	8.80%	-	-	-	-	Upgrade
Earnings Yield	1.20%	0.33%	-12.31%	-17.79%	-10.34%	-4.99%	Upgrade
FCF Yield	10.89%	9.97%	1.15%	-19.85%	-1.89%	-19.84%	Upgrade
Buyback Yield / Dilution	-0.84%	-3.74%	-23.89%	-34.06%	-27.55%	-8.41%	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.